The current price of CPRX is USD — it has decreased by −% in the past 24 hours. Watch Catalyst Pharmaceuticals, Inc. stock price performance more. Stock Price Forecast. The 6 analysts with month price forecasts for CPRX stock have an average target of , with a low estimate of 23 and a high estimate. Discover Catalyst Pharmaceuticals' earnings and revenue growth rates, forecasts, and the latest analyst predictions while comparing them to its industry. According to analysts, CPRX price target is USD with a max estimate of USD and a min estimate of USD. Check if this forecast comes true in a. Stock Price Targets. High, $ Median, $ Low, $ Average, $ Current Price, $ Yearly Numbers. Estimates. CPRX will report
Free Catalyst Pharmaceuticals (CPRX) analysis tools, including analyst ratings and target price forecasts, help you make informed investment decisions. Based on analysts offering 12 month price targets for CPRX in the last 3 months. The average price target is $30 with a high estimate of $31 and a low. The forecasts range from a low of $ to a high of $ The average price target represents an increase of % from the last closing price of $ The average stock forecast for Catalyst Pharmaceuticals Inc (CPRX) is USD. This price target corresponds to an upside of %. Catalyst Pharmaceuticals (CPRX) stock price prediction is USD. The Catalyst Pharmaceuticals stock forecast is USD for Several short-term signals are positive and the stock has broke the rising trend up, which indicates an even stronger rate of rising. We conclude that the. Catalyst Pharmaceuticals Stock Forecast Over the next 52 weeks, Catalyst Pharmaceuticals has on average historically risen by % based on the past 17 years. Catalyst Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CPRX updated stock price target summary. Catalyst Pharmaceuticals Inc. analyst estimates, including CPRX earnings Stock Price Targets. High, $ Median, $ Low, $ Average, $ Find the latest Catalyst Pharmaceuticals Inc (CPRX) stock forecast, month price target, predictions and analyst recommendations.
Get Catalyst Pharmaceuticals Inc (CPRX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Price Target. Argus• 6 days ago. Raising target price to $ CATALYST PHARMACEUTICALS INC has an Investment Rating of HOLD; a target price of $ Catalyst Pharma reported an EPS of $ in its last earnings report, beating expectations of $ Following the earnings report the stock price went up CPRX - Catalyst Pharmaceuticals - Stock Forecast CPRX is currently covered by 6 analysts with an average price target of $ This is a potential upside of. Catalyst Pharmaceuticals stock price target raised to $17 from $12 at Truist Catalyst Pharmaceuticals stock price target raised to $10 from $9 at Oppenheimer. Catalyst Pharmaceuticals Stock Forecast, CPRX stock price prediction. Price target in 14 days: USD. The best long-term & short-term Catalyst. Exchange. NASDAQ-CM ; Sector. Health Care ; Industry. Biotechnology: Pharmaceutical Preparations ; 1 Year Target. $ ; Today's High/Low. $/$ The Catalyst Pharmaceuticals stock forecast for tomorrow is $ , which would represent a % loss compared to the current price. In the next week, the. CPRX's current price target is $ Learn why top analysts are making this stock forecast for Catalyst Pharmaceuticals at MarketBeat.
Analyst Price Targets ; ; Average ; Current ; High. View Catalyst Pharmaceuticals, Inc. CPRX stock quote prices, financial information, real-time forecasts, and company news from CNN. Track Catalyst Pharmaceuticals Inc (CPRX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Achieved Q1 FIRDAPSE® net product revenue of $ Million, representing a substantial 34% YoY increase. On track to achieve forecast total revenues of. According to 6 analysts, the average rating for CPRX stock is "Strong Buy." The month stock price forecast is $, which is an increase of % from the.
Is Fidelity Good | Does It Cost Money To Join The Army